Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Summary
The goal of this clinical trail is to compare the differences in carotid plaque Treg cells' gene signature for activation, proliferation, and suppressive function using scRNA-seq in patients treated with IL-2 compared to control.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2023-08-26
Completion Date
2025-09-01
Last Updated
2025-05-30
Healthy Volunteers
No
Interventions
Interleukin-2 [IL-2]
5 sequential days of treatment (1.5MIU/day subcutaneously)
Standard care - Carotid Endarterectomy
Standard care for patients with carotid stenosis undergoing carotid endarterectomy
Locations (1)
Addenbrookes Hospital
Cambridge, Cambridgeshire, United Kingdom